Literature DB >> 7727652

Efficacy of liposomal amphotericin B in the treatment of visceral leishmaniasis in patients coinfected with the human immunodeficiency virus.

J Torre-Cisneros, J L Villanueva.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7727652     DOI： 10.1093/clinids/20.1.191

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  2 in total

1.  In vivo efficacy of oral and intralesional administration of 2-substituted quinolines in experimental treatment of new world cutaneous leishmaniasis caused by Leishmania amazonensis.

Authors:  A Fournet; M E Ferreira; A Rojas De Arias; S Torres De Ortiz; S Fuentes; H Nakayama; A Schinini; R Hocquemiller
Journal:  Antimicrob Agents Chemother       Date:  1996-11       Impact factor: 5.191

2.  Comparison of the efficacies of various formulations of amphotericin B against murine visceral leishmaniasis.

Authors:  A B Mullen; K C Carter; A J Baillie
Journal:  Antimicrob Agents Chemother       Date:  1997-10       Impact factor: 5.191
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.